Literature DB >> 11984871

Mouse dystrophin enhancer preferentially targets lacZ expression in skeletal and cardiac muscle.

Philip Marshall1, Nathalie Chartrand, Yves De Repentigny, Rashmi Kothary, Louise Pelletier, Rudi Mueller, Ronald G Worton.   

Abstract

Duchenne muscular dystrophy is a muscle wasting disease that results from a dystrophin deficiency in skeletal and cardiac muscle. Studies concerning the regulatory elements that govern dystrophin gene expression in skeletal and/or cardiac muscle in both mouse and human have identified a promoter and an enhancer located in intron 1. In transgenic mice, the muscle promoter alone targets the expression of a lacZ reporter gene only to the right ventricle of the heart, suggesting the need for other regulatory elements to target skeletal muscle and the rest of the heart. Here we report that the mouse dystrophin enhancer from intron 1 can target the expression of a lacZ reporter gene in skeletal muscle as well as in other heart compartments of transgenic mice. Our results also suggest that sequences surrounding the mouse dystrophin enhancer may affect its function throughout mouse development. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11984871     DOI: 10.1002/dvdy.10080

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  1 in total

1.  Transcription of the human uncoupling protein 3 gene is governed by a complex interplay between the promoter and intronic sequences.

Authors:  A Girousse; G Tavernier; C Tiraby; L Lichtenstein; J S Iacovoni; A Mairal; F Villarroya; D Langin
Journal:  Diabetologia       Date:  2009-05-26       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.